Avilar Therapeutics Alternatives & Competitors
12 companies similar to Avilar Therapeutics — Pioneering the discovery and development of extracellular protein degraders.
Companies similar to Avilar Therapeutics
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
San Diego, United States
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Woburn, United States
Rival Readout
Competing with Avilar Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Plexium
Pushing the Boundaries of Targeted Protein Degradation to Improve Lives
San Diego, United States
Celeris Therapeutics
The PIC Engineering Company.
Menlo Park, United States
C4 Therapeutics, Inc.
Clinical-stage biotech company transforming how disease is treated through targeted protei...
Watertown, United States
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
ProFound Therapeutics
Pioneering the expanded human proteome to reveal a universe of new medicines.
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
Cambridge, United Kingdom
Ashvattha Therapeutics, Inc.
Harnessing the power of hydroxyl dendrimers to create a new class of disease cell-targeted...
Redwood City, United Stat...
Peptone
Drugging disordered proteins with physics and AI
London, United Kingdom
About Avilar Therapeutics
Avilar Therapeutics, founded in 2020 and based in Waltham, MA, is a pioneering company in the Biotechnology and Pharmaceutical industries. Their slogan, "Pioneering the discovery and development of extracellular protein degraders," succinctly captures their innovative focus on targeted protein degradation. The company...
Development of novel protein degraders, Utilization of the endolysosome for protein degradation, Design and assembly of ATACs for extracellular proteins
Healthcare Providers, Pharmaceutical Companies, Biotechnology Researchers, Drug Development Organizations
Biopharmaceutical, Extracellular Protein Degraders, Targeted Protein Degradation, ASGPR Targeting Chimeras, ATAC Platform, Protein Degrader Therapeutics, Disease-Causing Proteins, Endolysosome, Small Molecule ASGPR Ligands, Pharmacokinetics, Pharmacodynamics, Endocytosis, Protein Pathogenesis, Drug Development, RA Capital Management
B2B, B2D, Platform
Licensing, Service Fee, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Avilar Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Avilar Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
